Where does Imnate Sarl rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Imnate Sarl ranks #40,870 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Imnate Sarl hold?

Imnate Sarl holds 6 US utility patents granted between 2017 and 2022, spanning 9 technology areas.

What is Imnate Sarl's Innovation Score?

Imnate Sarl has an Innovation Score of 24.8 out of 100 (15th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Imnate Sarl focus on?

Imnate Sarl's top technology area is C07K (Peptides) with 6 patents, ranking #1,362 of 3,615 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Imnate Sarl's patent grant rate increasing or decreasing?

Imnate Sarl's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Imnate Sarl's patents?

Imnate Sarl's patents average 6.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Imnate Sarl patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Imnate Sarl

USPTO PatentsView assignee record - 6 granted patents across 9 technology areas, recorded in grant years 2017–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Imnate ranks #40,870 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 9 technology areas.

#40,870
of 49,997 US assignees by volume: 15th percentile
by Innovation Score (24.8/100): 6.8
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R40870 · Foreign Corporation #40,870 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #40,870/49,997
PHOTO-FINISH Ignition Interfaces
CPC-NARROW C07K · 9 areas
INNOV-THIN 24.8/100
CLAIMS-SPARSE 6.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ignition Interfaces, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Imnate’s 24.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (27%) Velocity 3.3 pts (13%) Breadth 10.6 pts (43%) Claim depth 4.1 pts (17%)

Qualcomm Incorporated · highest

85
Imnate Sarl · this assignee

25
3D Lighting… · lowest

7

What this shows Imnate's Innovation Score is 24.8/100 (15th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Imnate?

Each dot is one of Imnate’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Imnate’s own 6.8 claims/patent is at or below the 16.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Imnate vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Imnate's grants concentrate

Imnate Sarl is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2017. By volume, Imnate sits between Ignition Interfaces, Inc. and Imunami Laboratories Pte. Ltd..

Imnate's three-year grant acceleration

Imnate Sarl shows 1 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ignition Interfac…

6
Ilion Medical

6
Illinois Grain &…

6
Immunsys

6
Impossible Diamond

6
Impress Group B V

6
Improved Racing P…

6
Imunami Laborator…

6
Imnate Sarl ◀

6

What this shows Imnate holds 6 patents at rank #40,958, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Imnate

By rank, the assignees closest to #40,958 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Imnate's primary technology class.

Imnate's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 15th percentile higher than 15% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Imnate Sarl patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	16.7%
2018	2	33.3%
2021	2	33.3%
2022	1	16.7%

Which technologies does Imnate Sarl patent most?

C07K - Peptides 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 2

C12Y - Enzymes 2

Y02A - Technologies FOR Adaptation TO Climate Change 1

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Imnate Sarl's patent record in context - here's where to go next.

Imnate Sarl's lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #40,870 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Imnate Sarl against Ignition Interfaces, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 24.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.